4min chapter

JAMA Clinical Reviews cover image

Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease

JAMA Clinical Reviews

CHAPTER

The Clinical Meaningfulness of DINANIMAB

Nearly all of the primary and secondary outcomes showed statistically significant benefit of DINANIMAB. A question that comes up a lot is the differences may be statistically significant, but are they clinically meaningful? Can you talk a little bit about how clinicians and patients might think about the clinical meaningfulness of the findings based on this study?

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode